← Back to headlines

FDA Faces Scrutiny Over Peptide Safety Concerns
The FDA is under fire for allegedly prioritizing speed over safety in its approach to regulating peptides, raising concerns about potential health risks.
3 Aug, 19:06 — 3 Aug, 19:06
Sources
Showing 1 of 1 sources



